Bayer Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Firm's fully automated BNP blood test gets FDA go-ahead for expanded claims to predict survival after myocardial infarction and assess heart failure severity. Run on Bayer's Advia Centaur and ACS:180 immunoassay systems, the test was cleared in 2003 to aid heart failure diagnosis...